USPTO serial 98900823
VITAPHARM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- TMO LAW OFFICE 119
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with VITAPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul Ditmyer
5 West Mendenhall Street #202Bozeman, MT 59715United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Haemoglobin; Iodine; Anti-inflammatories; Anti-inflammatory gels; Anti-inflammatory ointments; Anti-inflammatory preparations; Calcium fortified candy for medical purposes; Collagen for medical purposes; Dietary supplements; Dietary food supplements; Eucalyptus for pharmaceutical purposes; Folic acid dietary supplements; Gastro-intestinal treatment preparations; Headache treatment preparations; Iodine for pharmaceutical purposes; Lecithin dietary supplements; Lysine preparations; Mineral food supplements; Multivitamin preparations; Nausea treatment preparations; Probiotic preparations for medical use; Probiotic supplements; Urinary tract disinfectants; Vitamin B preparations; Vitamin C preparations; Zinc supplement lozenges; Albumin dietary supplements; Alginate dietary supplements; Allergy capsules; Analgesic and anti-inflammatory preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Casein dietary supplements; Central nervous system stimulants; Cod liver oil; Concentrated saline capsules for sinus and nasal irrigation; Diet capsules; Dietary supplements consisting primarily of iron; Dietary supplements consisting primarily of zinc and iron; Dietary supplements for urinary health; Enzyme food supplements; Food supplements; Fruit-based meal replacement bars for treating vitamin B12 deficiency that causes fatigue; Herbal supplements; Herbal male enhancement capsules; Homeopathic anti-inflammatory ointment; Linseed dietary supplements; Liquid herbal supplements; Mineral dietary supplements; Mineral nutritional supplements; Natural herbal supplements; Nutritional supplement shakes; Nutritional supplements in the form of capsules, tablets and liquids.; Nutritional supplements, namely, probiotic compositions; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Prebiotic supplements; Propolis dietary supplements; Protein supplement shakes; Stimulants for the central nervous system; Vitamin supplements; Vitamin and mineral supplements | ACTIVE | Jan 1, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 1, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 4, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2024 | NWAP | NEW APPLICATION ENTERED | — |